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Many members of the Staphylococcus genus are clinically relevant opportunistic
pathogens that warrant accurate and rapid identification for targeted therapy. The aim
of this study was to develop a careful assignment scheme for staphylococcal species
based on next-generation sequencing (NGS) of the 16S-23S rRNA region. All reference
staphylococcal strains were identified at the species level using Sanger sequencing of
the 16S rRNA, sodA, tuf, and rpoB genes and NGS of the 16S-23S rRNA region. To
broaden the database, an additional 100 staphylococcal strains, including 29 species,
were identified by routine diagnostic methods, 16S rRNA Sanger sequencing and NGS
of the 16S-23S rRNA region. The results enabled development of reference sequences
encompassing the 16S-23S rRNA region for 50 species (including one newly proposed
species) and 6 subspecies of the Staphylococcus genus. This study showed sodA and
rpoB targets were the most discriminative but NGS of the 16S-23S rRNA region was
more discriminative than tuf gene sequencing and much more discriminative than 16S
rRNA gene sequencing. Almost all Staphylococcus species could be distinguished when
the max score was 99.0% or higher and the sequence similarity between the best and
second best species was equal to or >0.2% (min. 9 nucleotides). This study allowed
development of reference sequences for 21 staphylococcal species and enrichment for
29 species for which sequences were publicly available. We confirmed the usefulness
of NGS of the 16S-23S rRNA region by identifying the whole species content in 45
clinical samples and comparing the results to those obtained using routine diagnostic
methods. Based on the developed reference database, all staphylococcal species can
be reliably detected based on the 16S-23S rRNA sequences in samples composed of
both single species and more complex polymicrobial communities. This study will be
useful for introduction of a novel diagnostic tool, which undoubtedly is an improvement
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for reliable species identification in polymicrobial samples. The introduction of this new
method is hindered by a lack of reference sequences for the 16S-23S rRNA region for
many bacterial species. The results will allow identification of all Staphylococcus species,
which are clinically relevant pathogens.
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INTRODUCTION
As of 2019, genus Staphylococcus comprises more than
50 validly described and proposed species, including
both coagulase-positive staphylococci (CoPS) and coagulase-
negative staphylococci (CoNS) (Euzéby, 1997; Becker
et al., 2014; Parte, 2018). Moreover, an additional CoNS
species (“S. pseudolugdunensis”) has been suggested
(Tang et al., 2008).
The staphylococci are opportunistic pathogens that are a part
of the natural microbiota of human and animal skin and mucous
membranes (Kaspar et al., 2016; Islam et al., 2017; Mrochen
et al., 2017; Kosecka-Strojek et al., 2018). However, changes in
patient populations, such as the increased number of premature
neonates, elderly and immunocompromised patients, and the
increasing use of implanted foreign prosthetic material and
indwelling catheters have led to a rise in documented infections
caused by CoNS and CoPS other than S. aureus (Flores-Mireles
et al., 2015; Giormezis et al., 2015; Butin et al., 2016; Savini
et al., 2016). Because most studies report such infections as
being caused by CoNS and do not differentiate isolates at the
species level, the real impact of single species, especially less
frequent species, is underreported. Moreover, species that have
only been discovered in the last few years are not part of the
routine diagnostic tests to identify bacterial species. Accurate
identification is highly desirable for precise therapy, monitoring
the spread of infections with epidemiologic characteristics and
investigating disease progression (Ghebremedhin et al., 2008;
Hwang et al., 2011; Shin et al., 2011; Becker et al., 2014).
In routine diagnostics, culture-dependent phenotypic tests,
including automated systems such as the Vitek 2 (bioMérieux,
La Balme Les Grottes, France) and BD Phoenix (BD Diagnostic
Systems, Sparks, MD, USA), and matrix-assisted laser desorption
ionization–time of flight mass spectrometry (MALDI-TOF MS),
are used for identification of bacterial species. However, these
methods are not always sufficiently reliable because of variable
expression of phenotypic characteristics, and the databases are
limited to only some species (Heikens et al., 2005; Dupont et al.,
2010; Bergeron et al., 2011; Becker et al., 2015; Singhal et al., 2015;
Ayeni et al., 2017; Gherardi et al., 2018). Accurate identification
at the species level may not only change the diagnosis but can
also help to identify unusual antimicrobial resistance patterns.
The ideal method should have high discriminatory power and
allow the identification of closely related species while also
being relatively simple, inexpensive, rapid and reproducible.
Therefore, genetic methods based on PCR or sequencing are
good candidates for identification purposes. Most of these
methods are based on specific nucleic acid target amplification
and sequencing (Couto et al., 2001; Drancourt and Raoult, 2002;
Becker et al., 2004).
For polymicrobial samples that need to be analyzed using
culture-independent tests, the simultaneous identification of
species of different genera using a single primer pair is a
useful approach. As the 16S rRNA gene is universally present
across bacteria, is highly conserved, and can be easily amplified
using universal primers, microbial analyses are often performed
using 16S rRNA amplicon sequencing (Nguyen et al., 2016).
Although this method is widely used and accurate, the high
degree of similarity between closely related species has limited
its usefulness for identifying several CoNS species as well as
distinguishing between the recently established species of the S.
aureus complex (Hwang et al., 2011; Shin et al., 2011; Sabat et al.,
2013; Tong et al., 2015).
Next-generation sequencing has highly improved
microbiological genetic investigations by providing a cost-
effective method to characterize bacterial genomes. The main
advantage of NGS over Sanger sequencing is its ability to
produce millions of reads in a single run. The NGS technologies
produce reads with high sequence quality and high throughput,
but the reads are short and need to be assembled de novo,
which can be challenging; therefore, qualified investigators are
highly desirable for NGS results analysis (Sabat et al., 2013).
Recently, a NGS-based method for the 16S-23S rRNA region
was developed by Sabat and colleagues (Sabat et al., 2017). This
method is based on PCR amplification of the 16S-23S rRNA
region, followed by amplicon sequencing on the MiSeq platform
(Illumina, Inc., San Diego, CA, USA). The resulting reads are
de novo assembled into contigs. Species identification is based
on alignment of the contig sequences with sequences deposited
in the reference databases (Sabat et al., 2017). This method
can be used for identification of common pathogens, such as
Staphylococcus aureus or Escherichia coli, directly from patient
specimens with a high identification potential. Identification is
also possible for non-cultured microorganisms, polymicrobial
samples or samples with a DNA concentration that is too low
for direct whole genome sequencing (WGS). However, the main
disadvantage of this method is a lack of 16S-23S rRNA reference
sequences for many bacterial species, which hinders proper
interpretation of the results (Sabat et al., 2017). The main aim
of this study was to develop a dataset of reference sequences of
the 16S-23S rRNA region for almost all staphylococcal species.
For validation of the dataset, we also compared the identification
potential of NGS of the 16S-23S rRNA region with Sanger
sequencing of the 16S rRNA, sodA, tuf and rpoB genes based on
whole database and determined the cut off values for genus- and
species-level identification of staphylococcal strains. Finally, we
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confirmed the applicability of NGS of the 16S-23S rRNA region
for species identification with 45 clinical samples using the newly
developed cut off values for staphylococcal species.
MATERIALS AND METHODS
Bacterial Isolates
The collection of bacterial reference strains used in this
study is described in Table 1. This collection included strains
from 50 staphylococcal species (including one proposed
species) and 6 subspecies. Most of the strains are deposited
in reference microorganism collections, such as the Polish
Collection of Microorganisms (PCM), Leibniz Institute DSMZ-
German Collection of Microorganisms and Cell Cultures
(DSMZ), American Type Culture Collection (ATCC), and
Belgian Coordinated Collection of Microorganisms (BCCM).
The collection with additional Staphylococcus strains is detailed
in Supplementary Table 1. This collection included 101 strains
originating from various human and animal infections and
environmental strains. All strains were cultivated on blood
agar medium with 5% sheep blood (bioMérieux, Marcy-l’Étoile,
France) in 37◦C for 20 h.
Clinical Samples
Forty-five clinical samples, collected in week 7 and 8 of
2018, from which the department of Medical Microbiology
at Certe (Groningen, The Netherlands) cultured at least one
Staphylococcus spp. were used. Bacterial identification was
performed using the MALDI-TOF Vitek R© MS. The clinical
samples consisted of; bronchoalveolar lavage (n = 1), catheter (n
= 2), cervix/vagina post-partum (n = 2), insertion opening (n =
1), nose (n= 4), pus abscess (n= 2), pus wound (n= 3), sputum
(n= 4), swab eye (n= 1), swab ulcer dig (n= 4), swab wound (n
= 1); throat (n = 2), urine (n = 13), wound superficial (n = 4),
and ear (n= 1).
Genomic DNA Extraction
For genomic DNA extraction, the isolates were grown for 18–
20 h at 37◦C on blood agar plates. A full inoculation loop of 10
µl of bacterial colonies was homogenized with a TissueLyser II
(Qiagen, Germantown, MD, USA). Total DNA was extracted by
enzymatic lysis using the buffers and solutions provided with
the DNeasy Blood and Tissue Kit (Qiagen, Germantown, MD,
USA) according to the manufacturer’s instructions. To obtain
accurate quantification of the extracted genomic DNA for NGS,
the Qubit dsDNA BR Assay Kit, which is a fluorometric method
specific for duplex DNA, and the Qubit fluorometer 2.0 (Life
Technologies, Inc., Eggenstein, Germany) were used according
to the manufacturer’s instructions.
Genomic DNA Extraction of Clinical
Samples
The Purelink Genomic DNA purification kit (Invitrogen,
Carlsbad, CA, USA) was used for DNA extraction. Briefly, initial
lysis was performed using 180 µl Purelink genomic digestion
buffer and 20µl Proteinase K. Digestion was performed in a
thermoshaker at 56◦C until lysis was complete. Two hundred
microliter Purelink Genomic lysis/binding buffer was added to
200 µl of lysed sample and vortexed to create a homogenous
solution. Two hundred microliter 96% ethanol was added and
the DNA purification protocol was followed according to the
manufacturer’s instructions.
PCR Amplification and Sanger Sequencing
of the 16S rRNA, sodA, tuf, and rpoB Genes
All reference strains were identified at the species level by
polymerase chain reaction (PCR) and Sanger sequencing of
the 16S rRNA, sodA, tuf, and rpoB genes. Additional strains
were identified at the species level by routine diagnostic
methods and 16S rRNA gene sequencing. The amplification
and sequencing primers and PCR conditions are listed in
Table 2. All PCR products were resolved by electrophoresis
using the 2200 TapeStation System (Agilent Technologies, Santa
Clara, CA, USA) and then purified using the DNA Clean &
ConcentratorTM-5 purification kit (Zymo Research, Irvine, CA,
USA). The pair-end Sanger sequencing with forward and reverse
strand sequencing was performed in GATC/ Eurofins Genomics
company (Ebersberg, Germany).
S. aureus and 16S rDNA Real-Time PCR of
Clinical Samples
In order to detect the presence of Staphylococcus DNA in clinical
samples, two real-time PCR assays were performed as showed
in Table 3. Firstly, the 16S rDNA assay was used to assess the
bacterial load followed by the more specific S. aureus real-
time PCR.
Next-Generation Sequencing of the
16S-23S rRNA Region
Amplification of the 16S-23S rRNA region was performed using
the primers 16S-27F (5′-AGAGTTTGATCMTGGCTCAG-
3′) and 23S-2490R (5′-GACATCGAGGTGCCAAAC-3′) as
described previously (Sabat et al., 2017). The PCR program for
pure strains was as follows: initial denaturation for 2min at
94◦C, followed by 30 cycles of denaturation at 94◦C for 30 sec,
annealing at 66◦C for 30 sec, and extension at 72◦C for 120 sec
and a final extension at 72◦C for 5min. For clinical samples,
inclusion of a polymerase (MTP Taq DNA Polymerase, Sigma-
Aldrich, St. Louis, MO, USA) recommended by the vendor for
clinical use was essential because contamination occurred in the
negative controls. To enhance the sensitivity of the PCR product,
the number of PCR cycles was increased to 35. The PCR program
used for clinical samples was as follows: initial denaturation for
2min at 94◦C, followed by 35 cycles of denaturation at 94◦C
for 30 sec, annealing at 66◦C for 30 sec, and extension at 72◦C
for 120 sec and a final extension at 72◦C for 5min. The same
program was used for the included controls. The obtained PCR
products were purified and the DNA libraries were prepared with
Nextera XT DNA Sample Preparation Kit (Illumina, Inc., San
Diego, CA, USA) according to the manufacturer’s instructions.
The indexed libraries were pooled and loaded onto an Illumina
MiSeq reagent cartridge using MiSeq reagent kit v3 and 600
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TABLE 1 | Staphylococcus reference species and subspecies used for analyses.
Species Strain number in reference
collection of microorganisms
Isolated from Country/References
S. agnetis DSM 23656 Bovine mastitic milk Finland
S. argensis DSM 29875 River sediment Germany
S. argenteus DSM 28299 Blood culture of a 55-year-old Indigenous
Australian female
Australia
S. arlettae LMG 19113 Poultry skin Belgium
S. aureus PL408a Natural environment Poland
S. auricularis PCM 2428 Human external ear Country of origin unknown
S. capitis subsp. capitis DSM 20326 Human skin Country of origin unknown
S. capitis subsp. urealyticus DSM 6717 Human skin Country of origin unknown
S. caprae DSM 20608 Goat milk Country of origin unknown
S. carnosus subsp. carnosus DSM 20501 Dry sausage Country of origin unknown
S. carnosus subsp. utilis DSM 11676 Fermented fish sauce (Pla-chom) Thailand
S. chromogenes PCM 2193 Skin of a healthy pig Devriese et al., 1978;
Hájek et al., 1986
S. cohnii subsp. cohnii PCM 2108 Human skin Schleifer and Kloos, 1975
S. condimenti DSM 11674 Soy sauce mash Japan
S. delphini PCM 2407 Aqarium dolphin purulent skin lesion Italy
S. devriesei CCUG 58238T Teat apex, healthy dairy heifer Belgium
S. epidermidis PCM 2532 Catheter Winslow and Winslow, 1908;
Evans, 1916
S. equorum PCM 2487 Horse skin Schleifer et al., 1984
S. felis DSM 7377 Mass on the auricle in cat Country of origin unknown
S. fleurettii DSM 13212 Goat milk cheese France
S. gallinarum DSM 20610 Skin of chicken Country of origin unknown
S. haemolyticus PCM 2113 Human skin Schleifer and Kloos, 1975
S. hominis subsp. hominis DSM 20328 Human skin Country of origin unknown
S. hominis subsp. novobiosepticus ATCC 700236 Human blood United States of America
S. hyicus PCM 2192 Skin of pig with exudative epidermitis Sompolinsky, 1953;
Devriese et al., 1978
S. intermedius DSM 20373 Pigeon nares Country of origin unknown
S. kloosii PCM 2440 Squirrel skin Schleifer et al., 1984
S. lentus PCM 2441 Goat udder France
S. lugdunensis PCM 2430 Axillary lymph node France
S. lutrae DSM 10244 Mammary gland of otter (Lutra lutra) Scotland
S. massiliensis CCUG 55927T Human brain abscess France
S. microti DSM 22147 Liver of free-living common vole
Microtus arvalis
Czech Republic
S. muscae PCM 2406 Fly Stomomyx calcitrans Czech Republic
S. nepalensis DSM 15150 Nasal mucosa of a goat Nepal
S. pasteuri PCM 2445 Human vomit France
S. petrasii subsp. jettensis DSM 26618 Human blood Belgium
S. petrasii subsp. pragensis DSM 102853 Ejaculate (58-year-old patient with chronical
prostatitis)
Czech Republic
S. pettenkoferi DSM 19554 Human blood culture Germany
S. piscifermentans PCM 2409 Fermented shrimp Thailand
S. pseudintermedius LMG 22219T Cat, lung tissue Belgium
“S. pseudolugdunensis” B006 Blood culture United States of America
S. rostri DSM 21968 Nasal cavity of a healthy pig Switzerland
S. saccharolyticus DSM20359 Plasma Country of origin unknown
S. saprophyticus subsp. bovis DSM 18669 Bovine nostril Czech Republic
S. saprophyticus subsp. saprophyticus DSM 100654 Cleanroom facility, TAS Italy
(Continued)
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TABLE 1 | Continued
Species Strain number in reference
collection of microorganisms
Isolated from Country/References
S. schleiferi subsp. schleiferi PCM 2426 Jugular catheter Country of origin unknown
S. schweitzeri DSM 28300 Nasal swab from a red-tailed monkey
(Cercopithecus ascanius) within 12 h after the
death of the animal
Gabon
S. sciuri PCM 2424 Skin of eastern gray squirrel (Sciurus
carolinensis)
Country of origin unknown
S. simiae DSM 17636 Feces, South American squirrel monkey Czech Republic
S. simulans PCM 2106 Human skin Kloos and Schleifer, 1975
S. stepanovicii CCM 7717T Animal vole Poland
S. succinus subsp. casei DSM 15096 Surface ripened cheese Switzerland
S. succinus subsp. succinus DSM 14617 Plant and soil inclusions within 25-35
million-year-old Dominican amber
Dominican Republic
S. vitulinus PCM 2470 Ground lamb Country of origin unknown
S. warneri DSM 20316 Human skin United States of America
S. xylosus PL412b Natural environment Poland
a,bEnvironmental isolates.
TABLE 2 | The amplification and Sanger sequencing primers and PCR conditions used for Staphylococcus species identification.









1. 94◦C for 2min
Steps 2–4 25 x
2. 94◦C for 30 sec
3. 58◦C for 30 sec
4. 72◦C for 60 sec
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1. 95◦C for 3min
Steps 2–4 35 x
2. 95◦C for 30 sec
3. 40◦C/43◦C/46◦C for 60 sec
4. 72◦C for 90 sec
5. 72◦C for 10min
d1, d2 100 ng Poyart et al., 2001




1. 95◦C for 5min
Steps 2–4 35 x
2. 95◦C for 30 sec
3. 55◦C for 60 sec
4. 72◦C for 90 sec
5. 72◦C for 7min
TSeq271, TSeq1138 200 ng Martineau et al.,
2001
rpoB (740-bp) Staph rpoB 1418f (5′- CAA
TTCATGGACCAAGC−3′)
Staph rpoB 3554r (5′-CCG
TCCCAAGTCATGAAAC-3′)
1. 94◦C for 5min
Steps 2–4 35 x
2. 94◦C for 30 sec
3. 52◦C for 30 sec
4. 72◦C for 60 sec
5. 72◦C for 5min
Staph rpoB 1418f, Staph
rpoB 1975r (5′-GCIACITGI
TCCATACCTGT-3′)
or Staph rpoB 1876r
(5′-GAGTCATCITTYTCTAAG
AATGG-3′)
250 ng Mellmann et al.,
2006
cycles. The 2 × 300 bp sequencing was run on an Illumina
MiSeq platform.
Data Analysis
The Sanger sequencing results were analyzed using the Chromas
software (Technelysium Pty Ltd., South Brisbane, Australia). The
obtained sequences were analyzed using nucleotide BLAST (Basic
Local Alignment Search Tool, http://www.ncbi.nlm.nih.gov/
BLAST/) and aligned to the reference sequences deposited in the
GenBank (v. 231.0; June 25, 2019) and leBIBI databases. The best
and the second best species alignments were analyzed.According
to the criteria developed by Sabat et al. (2017), the bacterial
species were assigned when the similarity score was 99% or
higher and the similarity score differences with the next closest
species was ≥0.2%. Therefore, the identification at the species
level using Sanger sequencing of the 16S rRNA (1284-bp), sodA
(430-bp), tuf (884-bp), and rpoB (740-bp) gene fragments was
considered as unambiguous for sequences different in at least
3, 2, 3, and 3 nucleotides, respectively. The identification at
the species level using NGS of the whole 16S-23S rRNA region
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Denaturation at 95◦C for 10
sec
Annealing at 55◦C for 10 sec
Extension at 72◦C for 90 sec
Schuurman
et al., 2004
(4.3-kb) was considered as unambiguous for sequences different
in at least 9 nucleotides. All sequences were compared with each
other and to whole public database. The sequences were aligned
in ClustalW (Larkin et al., 2007), and the phylogenetic trees
were constructed using the neighbor-joining method (Saitou and
Nei, 1987). The trees were drawn to scale, with branch lengths
in the same units as those of the evolutionary distances used
to infer the phylogenetic tree. The evolutionary distances were
computed using the Jukes-Cantor method (Tamura et al., 2004)
and were in the units of the number of base substitutions per site.
All positions containing gaps were eliminated. The evolutionary
analyses were conducted in MEGA7 (Kumar et al., 2016). The
pairwise comparison of each pair of sequences was obtained
using the CLC Genomics Workbench (Qiagen, Germantown,
MD, USA) considering deletions as differences.
The NGS generated 17,000–210,000 sequencing reads for pure
culture to obtain a minimum coverage of 1,000 per sample. The
fastq files (Illumina MiSeq) with read lengths of 250 or 300
nucleotides were de novo assembled with the DNASTAR SeqMan
NGen software (version 12.1.0; DNASTAR, Madison, WI, USA).
During read assembly, reads shorter than 250 nucleotides were
excluded. For most species, the minimum match percentage
was 85% or 93% and the mer size was set as 31 nucleotides.
The minimum matches of 94% were required for S. agnetis,
S. capitis subsp. capitis, S. pettenkoferi, and S. saprophyticus
subsp. saprophyticus and 86% for S. carnosus subsp. utilis, S.
haemolyticus, S. massiliensis, and S. nepalensis to obtain the best
quality sequences. After assembly, mean sample coverage was
4349.75-fold. However, the coverage per sample varied between
966.96- and 10649.1-fold. Only runs with a Q30 read quality
score of>80%were accepted. If the assembly resulted in multiple
contigs, the obtained ones were checked for length and quality
in order to select the longest main contig with the highest
reads amount assigned. Finally, the main contig was exported
as fasta file for use in the subsequent analyses. For all species
and subspecies, the main contig comprising the whole 16S-23S
rRNA region extending from 4,237 (S. epidermidis) to 4,625
nucleotides (S. lugdunensis) was obtained. For clinical samples,
the mer size was set as 31 nucleotides, and the minimum match
percentage was 93%. Most of the identified bacterial species or
genera were represented by a single contig of the expected size
of approximately 4,500 bp, but in some cases smaller contigs
ranging from 700 to 3,500 bp in size represented the same
bacterial species in a sample. If several contigs were annotated
to the same microorganism in some samples, the reads of these
contigs were added up. Species identification was based on
alignment of contig sequences with 16S-23S rRNA sequences
deposited in the GenBank database using nucleotide BLAST
and comparison to the leBIBI database (using the 16S rRNA
gene sequence as a reference). Additionally, all staphylococcal
species identifications were checked with the Staphylococcus
reference database. The bacterial species and genus were assigned
when the similarity scores were as previously described by
Sabat et al. (2017). A score below 90% was interpreted as an
unidentified organism.
Nucleotide Sequence Accession Numbers
The 380 sequences for 56 Staphylococcus species and subspecies
were annotated using the NCBI Sequin software and deposited in
the GenBank database (http://www.ncbi.nlm.nih.gov/genbank/)
under the following accession numbers: for the 16S-23S rRNA
region, MF678861–MF678916 and MK015765-MK015864; for
the 16S rRNA gene, MF678917-MF678972; for the sodA gene,
MF679029-MF679084; for the tuf gene, MF678973-MF679028;
and for the rpoB gene, MF679085-MF679140.
RESULTS
Sanger Sequencing of the 16S rRNA Gene
As presented in Table 4, Sanger sequencing of the 16S rRNA gene
allowed unambiguous identification at the species level for 27
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TABLE 4 | Summary of the performance of 16S rRNA, sodA, rpoB, tuf genes and 16S-23S rRNA region sequencing used for differentiation of Staphylococcus genus.
16S rRNA gene sodA gene tuf gene rpoB gene NGS 16S-23S rRNA
Unambiguous species identification 27 species (54%) 48 species (96%) 41 species (82%) 48 species (96%) 45 species (90%)
The lowest amount of nucleotides differences 0 0 0 0 0
The highest amount of nucleotides differences 57 149 120 192 667
No. of species without reference sequences in the databases 0 7 9 8 21
species (54% of all species). Identification of the following pairs
or groups of species was impossible because the 16S rRNA gene
sequences were identical or almost identical (1 or 2 nucleotide
differences): S. aureus - S. argenteus - S. schweitzeri; S. argensis
- S. pettenkoferi – “S. pseudolugdunensis”; S. pseudintermedius -
S. intermedius; S. piscifermentans - S. carnosus subsp. carnosus;
S. capitis subsp. urealyticus - S. caprae; S. agnetis – S. hyicus;
S. condimenti - S. carnosus; S. epidermidis - S. haemolyticus; S.
haemolyticus - S. equorum; S. gallinarum - S. haemolyticus; S.
cohnii - S. kloosii; S. cohnii - S. nepalensis; S. pasteuri - S. warneri;
S. microti - S. rostri; S. saprophyticus - S. xylosus; S. sciuri - S.
lugdunensis and S. vitulinus - S. aureus. The pairs of species S.
fleurettii - S. simulans, S. simulans - S. vitulinus and S. massiliensis
- S. vitulinus differed in the highest number of nucleotides, which
equaled 57 for each pair of sequences. Most subspecies were
not distinguishable by 16S rRNA gene sequencing. The only
exception was the pair S. petrasii subsp. jettensis – S. petrasii
subsp. pragensis, which differed by 6 nucleotides and could be
easily identified.
Sanger Sequencing of the rpoB Gene
Sanger sequencing of the rpoB gene allowed unambiguous
identification at the species level for 48 species (including
one proposed species), which constituted 96% of the species.
Identification of the following pairs or groups of species was
impossible because the rpoB gene sequences were identical
or almost identical: S. felis - S. cohnii and S. intermedius
- S. pseudintermedius. The rpoB sequences for eight species
(S. argensis, S. chromogenes, S. devriesei, S. massiliensis, S.
muscae, “S. pseudolugdunensis,” S. schweitzeri and S. stepanovicii)
were not available in the GenBank (v. 231.0; June 25, 2019)
database. Identification at the subspecies level was possible for
S. hominis subsp. hominis - S. hominis subsp. novobiosepticus,
S. petrasii subsp. jettensis - S. petrasii subsp. pragensis, and
S. succinus subsp. casei - S. succinus subsp. succinus using
the rpoB gene. Considering the nucleotide differences in the
rpoB gene sequences between pairs of species used within this
study, the pairs with the lowest differences were S. nepalensis
- S. stepanovicii (5 nucleotides) and S. pettenkoferi – “S.
pseudolugdunensis” (13 nucleotides). The pair with the highest
nucleotide difference was S. fleurettii - S. piscifermentans, which
differed in 192 nucleotides and was the highest difference among
those of all genes used in this study (Table 4).
Sanger Sequencing of the sodA Gene
Sanger sequencing of the sodA gene allowed unambiguous
identification at the species level for 48 species (including
one proposed species), which constituted 96% of the species.
Identification of the following pairs or groups of species was
impossible because the sodA gene sequences were identical or
almost identical: S. nepalensis - S. hominis and S. warneri -
S. epidermidis. The sodA gene sequences were not available in
the GenBank (v. 231.0; June 25, 2019) database for 7 species
(S. argensis, S. devriesei, S. petrasii, “S. pseudolugdunensis,”
S. schweitzeri, S. simiae, and S. stepanovicii) (Table 4). The
pairs of species used within this study with the lowest
nucleotide differences in the sodA gene sequences were S.
pettenkoferi – “S. pseudolugdunensis” (4 nucleotides), S. argensis
– “S. pseudolugdunensis” (6 nucleotides) and S. argensis - S.
pettenkoferi (8 nucleotides), and the pair with the highest
difference was S. aureus - S. fleurettii, which differed in 149
nucleotides (Table 4). Only the pair S. petrasii subsp. jettensis –
S. petrasii subsp. pragensis could be identified at the subspecies
level using sodA gene sequencing.
Sanger Sequencing of the tuf Gene
The tuf gene sequencing allowed identification at the species
level of 41 species, which accounted for 82% of all species. Due
to sequence similarities with another species, identification was
impossible for pairs: S. aureus - S. schweitzeri; S. microti - S. rostri;
S. pettenkoferi - “S. pseudolugdunensis”; S. pasteuri - S. warneri
and S. vitulinus - S. sciuri. For 9 species (S. argensis, S. devriesei,
S. microti, S. petrasii, S. piscifermentans, S. rostri, S. schweitzeri, S.
simiae and S. stepanovicii), the tuf gene reference sequences were
not available in the GenBank (v. 231.0; June 25, 2019) database.
The obtained results allowed the pairs with the lowest nucleotide
differences [S. delphini - S. pseudintermedius (3 nucleotides), S.
carnosus - S. condimenti (4 nucleotides), and S. argenteus - S.
aureus (5 nucleotides)] and the pair with the highest difference
[S. auricularis - S. vitulinus (120)] to be defined (Table 4). The tuf
gene sequencing also allowed identification at the subspecies level
for S. hominis subsp. hominis - S. hominis subsp. novobiosepticus
and S. petrasii subsp. jettensis - S. petrasii subsp. pragensis.
Next-Generation Sequencing of the
16S-23S rRNA Region
The nucleotide sequences of the 16S-23S rRNA region were
obtained for all staphylococcal species. Analysis of the GenBank
(v. 231.0; June 25, 2019) database showed that 16S-23S rRNA
region sequences were available for 29 Staphylococcus species,
whereas this study allowed the development of nucleotide
sequences for an additional 21 species. Taking into consideration
the differences in the length of the intergenic spacer located
between the 16S and 23S rRNA genes, the average sequence
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 August 2019 | Volume 9 | Article 278
Kosecka-Strojek et al. NGS-Based Identification of Staphylococcus Species
length of the 16S-23S rRNA region was determined and
equaled 4,381 nucleotides. The highest similarity among species
analyzed within this study was found between S. pettenkoferi and
“S. pseudolugdunensis” showing 99.8% sequence homology (7
nucleotides of difference), while the highest nucleotide difference
was found between S. delphini and S. fleurettii and equaled 667
nucleotides (85.6% similarity).
Comparison of the Sequencing Methods
All strains from the collection were characterized by Sanger
sequencing of the 16S rRNA, rpoB, sodA, and tuf genes but
identification to the species level was not possible by all targets
used due to identical or almost identical sequence or the lack
of some reference sequences in the GenBank (v. 231.0; June 25,
2019) database. The identification was confirmed by 2 targets for
4 species (S. aureus, S. pettenkoferi, “S. pseudolugdunensis” and S.
schweitzeri), by 3 targets for 12 species and by 4 targets for the
vast majority of the species (34 species) (Table 4).
To show the relationships among the species, phylogenetic
trees were constructed. The computed overall mean distances
according to the Jukes-Cantor model for the 16S rRNA,
sodA, tuf, and rpoB genes and the 16S-23S rRNA region
were 0.027, 0.023, 0.090, 0.178, and 0.045, respectively. Based
on the criteria used for phylogenetic tree construction, the
trees were constructed using the neighbor-joining method and
revealed that the isolates clustered into groups for all of the
methods used. All of the methods showed that S. massiliensis
and S. auricularis were distantly related to the other species
(Figure 1 and Supplementary Figures 1A–D). Analysis of the
phylogenetic tree of the 16S-23S region showed similar clustering
to the dendrogram based on 16S rRNA gene sequencing but was
more discriminative, with unambiguous identification of almost
all staphylococcal species (Figure 1).
For Staphylococcus species, sodA and rpoB genes Sanger
sequencing had the highest identification potential allowing for
an unambiguous identification of 96% of analyzed species, while
the NGS-based method allowed for identification of 90% species
(Table 4). The 16S rRNA gene Sanger sequencing had the lowest
identification potential of all the methods used.
The nucleotides differences in the 16S-23S rRNA region
sequences between pairs or species groups (S. aureus - S.
argenteus - S. schweitzeri, S. argensis - S. pettenkoferi –“S.
pseudolugdunensis,” S. pseudintermedius - S. intermedius, S.
piscifermentans - S. carnosus subsp. carnosus, and S. capitis subsp.
urealyticus - S. caprae) showed that all pairs or groups of species
indistinguishable by Sanger sequencing of the 16S rRNA gene
could be unambiguously identified with NGS of the 16S-23S
rRNA region (Table 5).
Additional Staphylococcal Strains
To compare the routine diagnostic methods with NGS of the 16S-
23S rRNA region for identification of Staphylococcus species, 101
staphylococcal strains isolated from human infections, animal
infections, natural environments and reference collections were
included (Supplementary Table 1). All strains were identified at
the species level by different standard diagnostic tools, such as
MALDI-TOF MS, VITEK R© 2 ID, the BD PhoenixTM system and
the API STAPH ID system. To confirm the obtained results, all
strains were identified using 16S rRNA gene sequencing. Finally,
all strains were identified by NGS of the 16S-23S rRNA region.
Of all of the strains, 76 (76.8%) were correctly identified and 25
(25.2%) were misidentified by the routine diagnostic methods.
The 16S rRNA sequencing allowed unambiguous identification
of only 32 strains (31.7%), whereas 69 strains (68.3%) were
incorrectly identified. NGS of the 16S-23S rRNA allowed
unambiguous identification of all strains, including one non-
staphylococcal strain misidentified by standard methods and also
unidentified by 16S rRNA sequencing as Shigella dysenteriae or
Escherichia coli. NGS of the 16S-23S region allowed unambiguous
identification of 5 S. pseudintermedius strains, which was not
possible with any other method used. Moreover, the reference
16S-23S rRNA sequence dataset allowed differentiation of one
S. agnetis strain that was aligned as S. hyicus by MALDI-TOF
MS and both 16S rRNA [1st ID: S. agnetis 1283/1283 (100%);
2nd ID: S. hyicus 1281/1283 (99.9%)] and 16S-23S rRNA region
sequencing [1st ID: S. agnetis 4422/4426 (99.9%); 2nd ID: S.
hyicus 4420/4426 (99.9%)] in comparison to GenBank (v. 231.0;
June 25, 2019).
Intraspecies Nucleotide Sequence
Variation of the 16S-23S rRNA Region
To show the variability of 16S-23S rRNA region, the nucleotide
sequence variation within Staphylococcus species was determined
(Table 6). The analysis was performed for those species for which
at least one nucleotide sequence of the 16S-23S rRNA region
could be found in the GenBank (v. 231.0; June 25, 2019) database.
For almost all species, the length of the 16S-23S rRNA region
was the same within a species when the sequences obtained
in this study and those deposited in GenBank (v. 231.0; June
25, 2019) were compared. The length of 16S-23S rRNA region
was different within the same species only in case of S. capitis
subsp. capitis, S. muscae, and S. pettenkoferi. The nucleotide
variation within Staphylococcus species accounted from 0.05 to
5.9%, with the exception of S. aureus, S. capitis, and S. sciuri
for which the intraspecies nucleotide variation was 9.70, 7.0, and
6.56%, respectively.
Clinical Samples
The aim of this part of our study was to assess the
potential of NGS of the 16S-23S rRNA region to improve
the resolution of Staphylococcus species identification directly
from clinical samples. Forty-five clinical samples from various
human infections were included (Table 7). Selection of these
samples was based on a positive culture for Staphylococcus
species. Staphylococcus species were identified by culture in all
45 samples, whereas NGS of the 16S-23S rRNA region identified
Staphylococcus species in 37 samples (STA1-STA6, STA8-
STA12, STA14-STA15, STA17-STA29, STA32-STA40, STA42, and
STA45). Among the analyzed samples, conventional culture
methods and NGS of the 16S-23S rRNA region identified
the same Staphylococcus species in 27 samples (STA1, STA4,
STA5, STA9- STA11, STA15, STA17- STA24, STA26- STA28,
STA32- STA34, STA36- STA40, and STA42). In 10 samples,
NGS of the 16S-23S rRNA region identified a higher number
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FIGURE 1 | Evolutionary relationships of staphylococci species based on 16S-23S rRNA region. The evolutionary history was inferred using the Neighbor-Joining
method. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1,000 replicates) are shown next to the branches. The
tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances
were computed using the Jukes-Cantor method and are in the units of the number of base substitutions per site. Evolutionary analyses were conducted in MEGA7.
The strains which are placed in boxes have grouped together in all methods used.
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S. schweitzeri 2/72 2/197
S. pettenkoferi 1/80




aThe nucleotides differences between the sequences of 16S rRNA gene and 16S-23S rRNA region for species used in this study are shown.
of Staphylococcus species than culture, showing two species
in samples STA6, STA8, STA12, and STA45, three species in
samples STA3, STA14, STA29, and STA35 and 4 and 6 species
in samples STA2 and STA25, respectively. In a few samples, the
culture-based methods allowed identification at the genus level,
whereas NGS of the 16S-23S rRNA region was able to identify
microorganisms at the species level (STA1, STA14, and STA31).
Moreover, the NGS-based approach showed other pathogens and
the coexisting microflora. The species content of the samples
identified by NGS contained a range from one (STA4, STA26, and
STA36) to a maximum of 33 (STA14) different microorganisms.
The Discrepancy Analysis of Identification
Results in Clinical Samples
Twenty four samples with both consistent and discrepant S.
aureus identification by culture and NGS-based approach were
selected for the 16S rRNA and S. aureus real-time PCR (Table 8).
For all selected samples the 16S rRNA assay revealed presence
of bacterial DNA and the S. aureus real-time PCR revealed the
presence of S. aureusDNAbetweenCt= 18 andCt= 33.1, and Ct
= 21.58 and Ct = 36, respectively. Comparing the results of the
differences in Ct values (1 Ct) between 16S rRNA and S. aureus
PCR, samples were divided into 3 groups. For the first one (STA2,
STA4, STA5, STA6, STA9, STA12, STA32, STA34, STA35, STA36,
STA37, STA42, and STA45) the NGS-based approach was able to
detect S. aureus at high level between 24.3 and 100% (reads in a
sample) and the 1 Ct values were the lowest counting from 0.03
to 2.42. The second group included samples (STA1, STA3, STA13,
STA33, STA38, and STA39) for which the1Ct values varied from
0.85 to 16.58 and the S. aureuswas detected at the bottom level of
0.2% tomaximum 8.5%. The third group consisted of the samples
for which the NGS-based approach failed to identify the S. aureus
(STA7, STA31, STA41, STA43, and STA44). For this group the
1 Ct values were very high at the level between 7.08 and 11.32.
Therefore, a lack of S. aureus detection with NGS-based approach
was a result of a low ratio between S. aureus DNA and total
bacterial DNA in a sample.
DISCUSSION
Because of the increasing clinical significance of CoNS (Becker
et al., 2014), accurate identification of staphylococci at the
species level is highly desirable to permit a more precise
determination of host-pathogen relationships and to better
understand the pathogenic potential of various staphylococcal
species. Phenotypic identification of CoNS appears to be
unsatisfactory, unreliable, and irreproducible (Heikens et al.,
2005; Dupont et al., 2010; Bergeron et al., 2011; Singhal et al.,
2015; Ayeni et al., 2017). Therefore, applying genetic methods
in standard microbiological diagnostics is necessary to improve
the identification process. When an unknown organism needs
to be identified in a clinical sample, 16S rRNA gene sequencing
is the method of choice because of the availability of universal
primers (Clarridge, 2004). The 16S rRNA gene sequencing is
an appropriate target for most staphylococcal species; however,
for some species, inter-species differentiation is difficult or
impossible due to missing or insufficient heterogeneity within
the 16S rRNA gene. Most reports show that the discriminatory
power of 16S rRNA gene sequencing is very low for closely related
Staphylococcus species (Heikens et al., 2005; Mellmann et al.,
2006; Woo et al., 2009; Shin et al., 2011; Lange et al., 2015).
Moreover, the accuracy of identification of bacterial species with
16S rRNA gene sequencing is hindered by the low quality of
many of the sequences deposited in public databases (Becker
et al., 2004). Other targeted sequencing methods may have a
higher identification potential than 16S rRNA gene sequencing
but often are limited to selected genera (Li et al., 2012). This study
showed sodA and rpoB targets were the most discriminative but
NGS of the 16S-23S rRNA region was more discriminative than
tuf gene sequencing and much more discriminative than 16S
rRNA gene sequencing based on obtained sequences and whole
database search. Moreover, the NGS-based method showed the
same clustering as the other methods (Figure 1). Because NGS of
the 16S-23S rRNA region uses universal primers, this method is
applicable to different and genetically unrelated bacterial genera.
Beyond the comparison of the five sequence-based methods
used for staphylococcal identification, the main purpose of this
study was to develop and validate a complete staphylococcal
reference sequence dataset for the 16S-23S rRNA region and
to evaluate the potential of this method for clinical samples.
The NGS of the 16S-23S rRNA region developed by Sabat
et al. (2017) provides the ability to detect microorganisms not
only in samples from mixed infections, which also consist of
commensal microorganisms, but also in whole microbiomes.
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TABLE 6 | The intraspecies polymorphism of 16S-23S rRNA region sequence within Staphylococcus genus.


















S. agnetis 2 (0.05%) 43 (0.97%) 1/0 4,427 2
S. argensis – – 0/0 4,364 1
S. argenteus 0 (0.00%) 14 (0.55%) 5/0 4,421 1
S. arlettae – – 0/0 4,316 3
S. aureus 0 (0.00%) 388 (9.70%) 365/78 4,389–4,589 4
S. auricularis 2 (0.05%) 2 (0.05%) 0/1 4,264 1
S. capitis 0 (0.00%) 322 (7.0%) 4/0 4,283–4,524 7
S. caprae 0 (0.00%) 169 (3.79%) 3/0 4,304–4,454 7
S. carnosus 0 (0.00%) 12 (0.28%) 2/0 4,288 3
S. chromogenes – – 0/0 4,410–4,323 2
S. cohnii 2 (0.05%) 101 (2.29%) 3/1 4,321–4,405 2
S. condimenti 0 (0.00%) 23 (1.44%) 2/1 4,288 1
S. delphini 0 (0.00%) 0 (0.00%) 0/1 4,578 1
S. devriesei – – 0/0 4,426 1
S. epidermidis 0 (0.00%) 257 (5.72%) 17/3 4,237–4,494 8
S. equorum 0 (0.00%) 7 (0.16%) 3/0 4,331 6
S. felis 1 (0.02%) 3 (0.07%) 1/0 4,431 2
S. fleurettii – – 0/0 4,300 2
S. gallinarum – – 0/0 4,322 3
S. haemolyticus 0 (0.00%) 271 (5.9%) 7/0 4,377–4,492 10
S. hominis 0 (0.00%) 180 (4.11%) 3/2 4,339–4,455 8
S. hyicus 0 (0.00%) 45 (1.02%) 1/2 4,422 1
S. intermedius – – – – 2
S. kloosii 1 (0.02%) 1 (0.02%) 1/0 4,442 1
S. lentus – – 0/0 4,328 3
S. lugdunensis 0 (0.00%) 144 (3.11%) 14/3 4,476–4,625 9
S. lutrae 4 (0.09%) 4 (0.09%) 1/0 4,267 1
S. massiliensis – – 0/0 4,277 1
S. microti – – 0/0 4,439 1
S. muscae 0 (0.00%) 30 (1.83%) 1/1 4,454 1
S. nepalensis 0 (0.00%) 92 (2.09%) 3/0 4,323–4,407 2
S. pasteuri 0 (0.00%) 150 (3.39%) 2/0 4,296–4,422 5
S. petrasii – – 0/0 4,328–4,457 2
S. pettenkoferi 19 (0.44%) 19 (0.44%) 1/0 4,299–4,317 2
S. piscifermentans 1 (0.02%) 1 (0.02%) 0/1 4,286 1
S. pseudintermedius 0 (0.00%) 180 (3.98%) 11/0 4,424–4,510 11
“S. pseudolugdunensis” – – 0/0 4,300 1
S. rostri – – 0/0 4,529 1
S. saccharolyticus – – 0/0 4,420 1
S. saprophyticus 0 (0.00%) 52 (3.22%) 5/2 4,326 5
S. schleiferi 0 (0.00%) 9 (0.21%) 6/0 4,293 1
S. schweitzeri 1 (0.02%) 1 (0.02%) 0/1 4,361 1
S. sciuri 0 (0.00%) 302 (6.56%) 2/1 4,295–4,505 6
S. simiae 3 (0.07%) 3 (0.07%) 0/1 4,331 1
S. simulans 0 (0.00%) 101 (2.31%) 6/2 4,287–4,380 4
S. stepanovicii 0 (0.00%) 0 (0.00%) 0/1 4,302 1
S. succinus 0 (0.00%) 6 (0.14%) 1/0 4,326 3
S. vitulinus – – 0/0 4,304 2
S. warneri 0 (0.00%) 101 (2.28%) 3/2 4,379–4,421 7
S. xylosus 0 (0.00%) 33 (0.76%) 4/1 4,331 4
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TABLE 7 | Bacterial identification results from 45 clinical samples based on culture and NGS of 16S-23S rRNA region.
Sample Sample
material
Species content by NGS of 16S-23S rRNA region (% of total reads) Species content by conventional culture




Streptococcus pyogenes (83.6%), Streptococcus dysgalactiae (15.5%),
Streptococcus sp. (0.6%), Staphylococcus aureus (0.2%)
Staphylococcus aureus (large),
Streptococcus pyogenes (large),
Streptococcus group G (large)
STA2 Nose Staphylococcus aureus (65.3%), Staphylococcus epidermidis (15.2%),
Corynebacterium sp. (6.4%), Cutibacterium acnes (4.4%), Staphylococcus
lugdunensis (2.1%), Finegoldia sp. (1.6%), Peptoniphilus sp. (0.7%), Streptococcus
sp. (0.5%), Cutibacterium sp. (0.5%), Cutibacterium granulosum (0.4%),
Staphylococcus sp. (0.3%), Micrococcus sp. (0.3%), Propionibacterium sp. (0.3%),
Kocuria palustris (0.2%), Herbaspirillum sp. (0.1%), Unidentified species (1.8%)
Staphylococcus aureus (medium)
STA3 Nose Corynebacterium sp. (32.9%), Staphylococcus aureus (7.8%), Corynebacterium
propinquum (3.3%), Streptococcus oralis (1.9%), Streptococcus canis (1.6%),
Cutibacterium acnes (1.5%), Staphylococcus epidermidis (0.8%), Streptococcus
sp. (0.7%), Neisseria sicca (0.4%), Actinomyces sp. (0.4%), Finegoldia sp. (0.3%),
Veillonella sp. (0.3%), Corynebacterium pseudodiphtheriticum (0.3%), Herbaspirillum
sp. (0.2%), Staphylococcus sp. (0.1%), Capnocytophaga sp. (0.1%), Enterococcus
sp. (0.1%), Fusobacterium hwasookii (0.1%), Anaerococcus sp. (0.1%), Unidentified
species (47.0%), eukaryotic DNA (0.1%)
Staphylococcus aureus (few)
STA4 Swab ulcus dig. Staphylococcus aureus (100%) Staphylococcus aureus (medium)
STA5 Swab ulcus dig. Staphylococcus aureus (59.6%), Streptococcus dysgalactiae (23.7%),
Streptococcus sp. (3.1%), Streptococcus pneumoniae (2.7%), Herbaspirillum sp.
(1.8%), Sphingomonas sanguinis (0.7%), Gemella haemolysans (0.3%), eukaryotic
DNA (8.2%)
Staphylococcus aureus (medium)
STA6 Pus abscess Staphylococcus aureus (95.5%), Staphylococcus capitis (0.8%), Cutibacterium




Finegoldia sp. (45.6%), Anaerococcus tetradius (7.6%), Peptoniphilus harei (7.4%),
Peptoniphilus coxii (7.2%), Streptococcus sp. (6.8%), Prevotella sp. (3.2%),
Streptococcus agalactiae (2.1%), Anaerococcus obesiensis (1.9%), Prevotella disiens





Staphylococcus epidermidis (71.8%), Staphylococcus lugdunensis (17.7%),
Streptococcus sp. (4.2%), Streptococcus parasanguinis (2.0%), Herbaspirillum sp.
(1.0%), Streptococcus mitis (0.5%), Sphingomonas sanguinis (0.5%), Streptococcus




Streptococcus agalactiae (28.3%), Staphylococcus aureus (24.3%), Peptoniphilus
harei (12.7%), Finegoldia magna (7.3%), Anaerococcus sp. (6.7%), Peptoniphilus
coxii (4.8%), Anaerococcus vaginalis (2.9%), Fastidiosipila sp. (2.8%),
Porphyromonas bennonis (0.6%), Actinotignum sp. (0.6%), Corynebacterium sp.
(0.4%), Varibaculum cambriense (0.2%), Fastidiosipila sanguinis (0.2%),
Cutibacterium acnes (0.1%), Staphylococcus capitis (0.1%), Streptococcus sp.





Staphylococcus epidermidis (81.9%), Herbaspirillum sp. (5.6%), Sphingomonas
sanguinis (5.4%), Streptococcus thermophilus (2.2%), Paracoccus sp. (1.1%),
Unidentified species (0.7%), eukaryotic DNA (3.0%)
Staphylococcus epidermidis (few)
STA11 Nose Staphylococcus epidermidis (45.2%), Psychrobacter alimentarius (29.3%),
Corynebacterium accolens (15.2%), Peptoniphilus sp. (2.9%), Anaerococcus sp.
(2.5%), Corynebacterium sp. (1.3%), Cutibacterium granulosum (1.1%),
Corynebacterium pseudodiphtheriticum (0.7%), Propionibacterium sp. (0.3%),
Sphingomonas sanguinis (0.1%), Kocuria rhizophila (0.1%), Herbaspirillum sp. (0.1%),
Unidentified species (1.1%)
Staphylococcus epidermidis (few)
STA12 Swab ulcus dig. Staphylococcus aureus (55.0%), Streptococcus oralis (28.2%), Pseudomonas
aeruginosa (10.1%), Finegoldia magna (4.9%), Morganella morganii (0.7%),
Streptococcus pneumoniae (0.3%), Herbaspirillum sp. (0.2%), Anaerococcus sp.





Megasphaera sp. (33.8%), Atopobium sp. (6.4%), Lactobacillus sp. (3.8%),
Aerococcus sp. (1.5%), Peptostreptococcus sp. (1.4%), Staphylococcus sp.
(0.9%), Anaerococcus tetradius (0.3%), Prevotella sp. (0.3%), Peptoniphilus sp.
(0.3%), Gemella asaccharolytica (0.2%), Arcanobacterium sp. (0.2%), Streptococcus
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TABLE 7 | Continued
Sample Sample
material
Species content by NGS of 16S-23S rRNA region (% of total reads) Species content by conventional culture
and MALDI-TOF Vitek MS identification
(growth)
STA14 Throat Faecalibacterium prausnitzii (10.8%), Streptococcus salivarius (5.9%),
Staphylococcus epidermidis (4.9%), Oscillibacter sp. (3.2%), Bacteroides vulgatus
(2.9%), Bacteroides uniformis (2.6%), Alistipes sp. (2.0%), Staphylococcus
lugdunensis (1.9%), Lactobacillus sp. (1.7%), Escherichia coli (1.7%), Roseburia sp.
(1.6%), Eubacterium sp. (1.2%), Barnesiella sp. (1.0%), Enterococcus faecium (0.9%),
Eubacterium rectale (0.8%), Acutalibacter sp. (0.7%), Porphyromonas bennonis
(0.7%), Monoglobus pectinilyticus (0.5%), Longibaculum sp. (0.5%), Blautia sp.
(0.5%), Eubacterium siraeum (0.5%), Parabacteroides distasonis (0.4%),
Staphylococcus sp. (0.4%), Bacteroides sp. (0.4%), Ruminococcus sp. (0.3%),
Peptoniphilus sp. (0.3%), Herbaspirillum sp. (0.3%), Dialister sp. (0.3%),
Intestinimonas sp. (0.3%), Parabacteroides sp. (0.3%), Sphingomonas zeae (0.2%),
Colidextribacter massiliensis (0.2%), Odoribacter splanchnicus (0.2%), Unidentified
species (45.0%), eukaryotic DNA (4.6%)
Escherichia coli (medium), Staphylococcus
spp. (few)
STA15 Urine Actinotignum sp. (68.2%), Staphylococcus epidermidis (31.1%), Actinotignum
schaalii (0.1%), Unidentified species (0.6%)
Staphylococcus epidermidis (≥10e5
CFU/ml.)
STA16 Urine Lactobacillus sp. (98.5%), Lactobacillus iners (0.8%), Unidentified species (0.7%) Staphylococcus haemolyticus (≥10e5
CFU/ml.)
STA17 Sputum Prevotella melaninogenica (76.9%), Staphylococcus haemolyticus (10.0%),
Leptotrichia sp. (5.7%), Veillonella sp. (0.1%), Prevotella jejuni (0.1%), Prevotella sp.
(0.1%), Unidentified species (7.1%)
Staphylococcus haemolyticus (medium)
STA18 Cathether Staphylococcus epidermidis (90.8%), Enterococcus faecalis (4.1%), Enterococcus
hirae (1.7%), Herbaspirillum sp. (1.2%), Sphingomonas sanguinis (0.9%), Roseateles
sp. (0.5%), Ralstonia insidiosa (0.2%), eukaryotic DNA (0.6%)
Staphylococcus epidermidis (≥ 15 CFU),
Enterococcus faecium (1 CFU)
STA19 Urine Staphylococcus epidermidis (91.9%), Herbaspirillum sp. (5.6%), Sphingomonas




STA20 Cathether Staphylococcus epidermidis (76.4%), Herbaspirillum sp. (8.4%),
Janthinobacterium svalbardensis (2.0%), Sphingomonas sanguinis (1.2%),
Staphylococcus capitis (1.2%), Roseateles sp. (0.7%), Corynebacterium accolens
(0.5%), Pseudomonas sp. (0.4%), Rhizobacter sp. (0.3%), Unidentified species
(2.3%), eukaryotic DNA (6.5%)
Staphylococcus capitis (≥15 CFU),
Staphylococcus epidermidis (≥15 CFU)
STA21 Urine Staphylococcus epidermidis (72.5%), Bacteroides dorei (20.2%), Bacteroides
fragilis (6.6%), Unidentified species (0.8%)
Staphylococcus epidermidis (≥10e5
CFU/ml.)
STA22 Urine Staphylococcus haemolyticus (65.1%), Dialister sp. (4.2%), Actinomyces sp.
(1.6%), Solobacterium moorei (1.5%), Cutibacterium acnes (1.1%), Peptoniphilus
lacrimalis (1.1%), Prevotella sp. (0.9%), Actinotignum sp. (0.9%), Porphyromonas
bennonis (0.7%), Herbaspirillum sp. (0.7%), Eubacterium saphenum (0.5%),
Peptoniphilus grossensis (0.5%), Peptoniphilus urinimassiliensis (0.4%), Kallipyga sp.
(0.4%), Eubacterium sp. (0.4%), Jonquetella anthropic (0.3%), Peptoniphilus
koenoeneniae (0.3%), Actinomyces turicensis (0.3%), Criibacterium bergeronii (0.2%),
Ezakiella sp. (0.2%), Prevotella colorans (0.2%), Roseateles sp. (0.2%),




STA23 Urine Staphylococcus saprophyticus (96.9%), Veillonella sp. (1.1%), Streptococcus
agalactiae (0.8%), Herbaspirillum sp. (0.2%), Moraxella osloensis (0.2%),




STA24 Swab eye Cutibacterium acnes (47.5%), Corynebacterium sp. (9.7%), Staphylococcus
epidermidis (4.4%), Streptococcus sanguinis (4.3%), Herbaspirillum sp. (4.2%),
Simonsiella sp. (1.6%), Veillonella sp. (1.3%), Sphingomonas sanguinis (1.2%),
Corynebacterium jeikeium (1.2%), Roseateles sp. (0.9%), Gordonia sp. (0.8%),
Fusobacterium nucleatum (0.8%), Finegoldia sp. (0.6%), Aquabacterium sp. (0.5%),
Kocuria palustris (0.5%), Methylobacterium sp. (0.4%), Kocuria rhizophila (1.5%),
Propionibacterium acnes (0.4%), eukaryotic DNA (18.2%)
Staphylococcus epidermidis (unknown)
STA25 Nose Staphylococcus epidermidis (69.3%), Finegoldia magna (7.9%) Sphingomonas
sanguinis (3.6%), Herbaspirillum sp. (3.4%), Pseudomonas fluorescens (2.4%),
Staphylococcus haemolyticus (1.8%), Streptococcus sanguinis (1.6%),
Staphylococcus pasteuri (unknown)
(Continued)
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TABLE 7 | Continued
Sample Sample
material
Species content by NGS of 16S-23S rRNA region (% of total reads) Species content by conventional culture
and MALDI-TOF Vitek MS identification
(growth)
Enterococcus faecalis (1.5%), Staphylococcus sp. (1.2%), Kocuria palustris (1.0%),
Staphylococcus hominis (0.7%), Niastella sp. (0.6%), Staphylococcus pasteuri
(0.6%), Corynebacterium sp. (0.4%), Propionibacterium acnes (0.4%),
Staphylococcus capitis (0.3%), Janthinobacterium sp. (0.2%), Roseateles sp.
(0.2%), Campylobacter concisus (0.2%), Streptococcus sp. (0.2%), Actinomyces
neuii (0.2%), Unidentified species (1.5%), eukaryotic DNA (0.8%)
STA26 Urine Staphylococcus lugdunensis (100%) Staphylococcus lugdunensis (≥10e5
CFU/ml.)




STA28 Urine Aerococcus urinae (95.7%), Staphylococcus sp. (3.6%), Unidentified species (0.7%) Staphylococcus epidermidis (≥10e5




Staphylococcus haemolyticus (43.1%), Herminiimonas sp. (11.2%),
Propionibacterium acnes (9.2%), Sphingomonas sanguinis (6.6%), Staphylococcus
epidermidis (6.3%), Paracoccus yeei (3.4%), Janthinobacterium sp. (1.7%),
Herbaspirillum sp. (1.6%), Pseudomonas sp. (0.3%), Pseudomonas lurida (0.3%),






Corynebacterium sp. (52.0%), Peptoniphilus harei (31.5%), Corynebacterium
tuberculostearicum (1.6%), Cutibacterium acnes (1.1%), Anaerococcus sp. (0.7%),
Finegoldia sp. (0.7%), Herbaspirillum sp. (0.5%), Corynebacterium pseudogenitalium







Streptococcus dysgalactiae (98.8%), Corynebacterium sp. (0.5%), Finegoldia sp.
(0.4%), Unidentified species (0.3%)
Staphylococcus aureus (medium),
Streptococcus group C (large)
STA32 Throat Staphylococcus aureus (98.4%), Corynebacterium striatum (1.0%),
Peptostreptococcus anaerobius (0.4%), Streptococcus sp. (0.2%)
Staphylococcus aureus (medium)
STA33 Ear Finegoldia sp. (37.6%), Gemella haemolysans (11.5%), Anaerococcus sp. (7.2%),
Streptococcus pneumoniae (4.0%), Staphylococcus sp. (2.3%), Enterococcus sp.
(1.9%), Peptoniphilus harei (1.2%), Prevotella sp. (1.0%), Eikenella corrodens (0.9%),
Corynebacterium sp. (0.6%), Staphylococcus aureus (0.4%), Auricoccus sp.
(0.4%), Prevotella melaninogenica (0.3%), Unidentified species (29.9%), eukaryotic
DNA (0.9%)
Staphylococcus aureus (large)
STA34 Urine Staphylococcus aureus (68.7%), Peptostreptococcus anaerobius (7.6%),
Anaerococcus tetradius (2.2%), Anaerococcus sp. (1.4%), Peptoniphilus harei (0.6%),
Corynebacterium simulans (0.5%), Herbaspirillum sp. (0.2%), Sphingomonas
sanguinis (0.2%), Corynebacterium sp. (0.2%), Pedobacter sp. (0.2%), Unidentified
species (16.9%), eukaryotic DNA (1.8%)
Staphylococcus aureus (≥ 10e5 CFU/ml.)
STA35 Urine Staphylococcus aureus (98.4%), Staphylococcus haemolyticus (1.0%),
Staphylococcus epidermidis (0.5%)
Staphylococcus aureus (≥ 10e5 CFU/ml.),
Candida parapsilosis (10e4 CFU/ml.)
STA36 Urine Staphylococcus aureus (100%) Staphylococcus aureus (≥ 10e5 CFU/ml.)
STA37 Sputum Staphylococcus aureus (62.4%), Streptococcus sp. (16.6%), Fusobacterium sp.
(5.2%), Fusobacterium nucleatum (3.6%), Veillonella atypica (3.2%), Gemella
morbillorum (1.3%), Prevotella sp. (0.9%), Prevotella conceptionensis (0.6%),
Prevotella melaninogenica (0.5%), Parvimonas micra (0.5%), Streptococcus salivarius
(0.4%), Capnocytophaga sp. (0.2%), Lactobacillus gasseri (0.2%), Streptococcus
parasanguinis (0.2%), Unidentified species (1.4%), eukaryotic DNA (2.8%)
Staphylococcus aureus (large)
STA38 Urine Klebsiella sp. (61.5%), Pseudomonas sp. (29.6%), Staphylococcus aureus (2.7%),
Stenotrophomonas sp. (0.6%), Acinetobacter sp. (0.3%), Enterobacter sp. (0.3%),
Klebsiella oxytoca (0.3%), Pseudomonas azotoformans (0.1%), Unidentified species
(4.7%)
Staphylococcus aureus (≥ 10e5 CFU/ml.),
Klebsiella oxytoca (≥ 10e5 CFU/ml.)
STA39 Sputum Streptococcus anginosus (32.0%), Prevotella sp. (26.9%), Moraxella catarrhalis
(13.9%), Staphylococcus aureus (8.5%), Prevotella oris (3.5%), Solobacterium
moorei (1.6%), Streptococcus sp. (1.1%), Peptoniphilus harei (0.6%),
Corynebacterium sp. (0.5%), Parvimonas micra (0.4%), Finegoldia sp. (0.3%),
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TABLE 7 | Continued
Sample Sample
material
Species content by NGS of 16S-23S rRNA region (% of total reads) Species content by conventional culture
and MALDI-TOF Vitek MS identification
(growth)
STA40 Sputum Staphylococcus aureus (8.5%), Leptotrichia sp. (2.3%), Streptococcus
thermophilus (1.7%), Herbaspirillum sp. (1.5%), eukaryotic DNA (85.9%)
Staphylococcus aureus (few), Candida
albicans (few)
STA41 BAL Leptotrichia sp. (37.4%), Prevotella sp. (13.5%), Streptococcus sp. (10.7%),
Veillonella atypica (5.2%), Fusobacterium sp. (1.4%), Selenomonas sp. (1.3%),
Actinomyces sp. (0.8%), Parvimonas sp. (0.8%), Megasphaera sp. (0.7%),
Atopobium sp. (0.6%), Streptococcus salivarius (0.5%), Tannerella sp. (0.3%),
Lactobacillus sp. (0.3%), Cryptobacterium sp. (0.3%), Porphyromonas sp. (0.3%),
Aerococcus sp. (0.2%), Prevotella melaninogenica (0.2%), Alloprevotella tannerae
(0.2%), Dialister sp. (0.2%), Dialister pneumosintes (0.2%), Fretibacterium fastidiosum
(0.2%), Mogibacterium sp. (0.2%), Stomatobaculum longum (0.2%), Centipeda sp.
(0.2%), Peptostreptococcus sp. (0.1%), Prevotella nigrescens (0.1%), Streptococcus
mitis (0.1%), Actinomyces odontolyticus (0.1%), Anaeroglobus sp. (0.1%), Atopobium
parvulum (0.1%), Solobacterium sp. (0.1%), Eubacterium sp. (0.1%), Unidentified
species (23.6%)




Staphylococcus aureus (30.8%), Mobiluncus curtisii (5.1%), Dialister sp. (1.8%),
Anaerococcus sp. (1.7%), Actinomyces sp. (1.4%), Peptoniphilus coxii (1.1%),
Herbaspirillum sp. (0.8%), Peptoniphilus sp. (0.6%), Peptoniphilus harei (0.6%),





Lactobacillus sp. (50.7%), Prevotella sp. (17.4%), Parvimonas sp. (5.7%),
Streptococcus anginosus (1.3%), Gemella sp. (1.1%), Solobacterium sp. (0.7%),
Anaerococcus obesiensis (0.4%), Peptoniphilus sp. (0.3%), Lactobacillus iners (0.2%),
Solobacterium moorei (0.1%), Unidentified species (22.1%), eukaryotic DNA (0.1%)
Staphylococcus aureus (large), Escherichia
coli (large), Prevotella disiens (medium)
STA44 Wound
supperficial
Streptococcus agalactiae (65.5%), Finegoldia sp. (10.2%), Anaerococcus sp. (3.4%),
Actinotignum sp. (0.5%), Peptoniphilus sp. (0.4%), Actinomyces sp. (0.1%),
Enterococcus sp. (0.1%), Unidentified species (19.9%)
Staphylococcus aureus (large),
Streptococcus agalactiae (large)
STA45 Swab ulcus dig. Staphylococcus aureus (63.4%), Streptococcus oralis (23.4%), Staphylococcus
sp. (7.0%), Finegoldia magna (3.5%), Pseudomonas aeruginosa (0.4%),
Anaerococcus murdochii (0.2%), Corynebacterium striatum (0.2%), Actinomyces
neuii (0.2%), Unidentified species (1.8%)
Staphylococcus aureus (medium),
Pseudomonas aeruginosa (medium)
All detected Staphylococcus species are indicated in bold.
However, this method suffers from a lack of reference sequences
in the GenBank database for many bacterial species at present.
Prior to this study, 16S-23S rRNA sequences were available
for only 29 Staphylococcus species. Our investigations allowed
development of 16S-23S rRNA sequences for an additional
21 species, making identification of almost all Staphylococcus
species feasible with the exception only of the recently described
Antarctic S. edaphicus species (Pantøuček et al., 2017).
In order to identify strains at the species level, the reference
sequence with the highest similarity score needs to be found. For
several Staphylococcus species, only one or a few reference 16S-
23S rRNA sequences can be found during BLAST searches in the
GenBank database. In such cases, it is possible that the sequence
obtained during a study belongs to a different evolutionary
cluster within a species than the reference and the nucleotide
differences between them are high (more than 1%). Then, it is
not possible to assign bacterial species with the similarity score
99% or higher. If more reference sequences are deposited in
the genetic sequence databases, representing evolutionary diverse
lineages, species will always be assigned with a similarity score
above 99%.
The NGS of 16S-23S rRNA approach proved to be an excellent
tool for identification at the species level for a great majority
of Staphylococcus strains. Nevertheless, some problematic cases
were found. In our study, in case of pairs: S. pseudintermedius
– S. aureus; S. simulans – S. hyicus and S. warneri – S.
epidermidis, an alignment to the next closest species accounted
<0.2% but to only one and not published genome assembly.
In all these cases, the second next species was aligned <99%
similarity. Similar situation was found for S. agnetis – S. hyicus
and S. schweitzeri – S. aureus. As the problems in accurate
identification of these species are described (Tong et al., 2015;
Adkins et al., 2017), we believe that the increase of deposited
sequences for S. agnetis and S. schweitzeri will allow for an
unequivocal identification. It is very important to develop a
well-curated database with a verification of deposited sequences
in terms of proper organism identification. For now, the
sequences that are not published should not be considered as
reference ones. There is no previous single study with a same
dataset of reference sequences for genes commonly used for
staphylococci identification, so usually those sequences cannot
be compared. In this study, we have not only deposited such
dataset for 4 commonly used identification targets but also added
a package of sequences for a new identification tool with a high
identification potential.
The developed reference dataset improved the identification
accuracy of staphylococci in clinical samples. Data from this
study showed that NGS of the 16S-23S rRNA region for most
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TABLE 8 | The discrepancy analysis of 24 clinical samples with real-time PCR.
Sample S. aureus PCR
(Ct)
16S rDNA (Ct) 1 Ct S. aureus identification with NGS of
16S-23S rRNA region (% of total
reads)
S. aureus identification with
conventional culture and MALDI-TOF
Vitek MS identification (growth)
STA4 25.32 25.04 0.28 Staphylococcus aureus (100%) Staphylococcus aureus (medium)
STA36 24.31 23.86 0.45 Staphylococcus aureus (100%) Staphylococcus aureus (≥10e5 CFU/ml.)
STA32 25.23 23.70 1.53 Staphylococcus aureus (98.4%) Staphylococcus aureus (medium)
STA35 21.58 20.91 0.67 Staphylococcus aureus (98.4%) Staphylococcus aureus (≥10e5 CFU/ml.)
STA6 25.72 25.69 0.03 Staphylococcus aureus (95.5%) Staphylococcus aureus (medium)
STA34 28.26 29.70 1.44 Staphylococcus aureus (68.7%) Staphylococcus aureus (≥10e5 CFU/ml.)
STA37 27.01 24.59 2.42 Staphylococcus aureus (62.4%) Staphylococcus aureus (large)
STA2 27.78 27.20 0.58 Staphylococcus aureus (65.3%) Staphylococcus aureus (medium)
STA45 26.26 25.51 0.75 Staphylococcus aureus (63.4%) Staphylococcus aureus (medium)
STA5 31.83 32.86 1.03 Staphylococcus aureus (59.6%) Staphylococcus aureus (medium)
STA12 25.25 26.72 1.53 Staphylococcus aureus (55.0%) Staphylococcus aureus (medium)
STA42 31.29 33.1 1.81 Staphylococcus aureus (30.8%) Staphylococcus aureus (medium)
STA9 26.49 25.87 0.62 Staphylococcus aureus (24.3%) Staphylococcus aureus (medium)
STA39 25.13 19.22 5.91 Staphylococcus aureus (8.5%) Staphylococcus aureus (large)
STA3 31.30 30.45 0.85 Staphylococcus aureus (7.8%) Staphylococcus aureus (few)
STA38 26.73 18.00 8.73 Staphylococcus aureus (2.7%) Staphylococcus aureus (≥10e5 CFU/ml.)
STA13 34.79 18.21 16.58 Staphylococcus sp. (0.9%) Staphylococcus haemolyticus (sporadic),
Staphylococcus epidermidis (large)
STA33 26.86 25.15 1.71 Staphylococcus aureus (0.4%) Staphylococcus aureus (large)
STA1 33.10 21.86 11.15 Staphylococcus aureus (0.2%) Staphylococcus aureus (large)
STA7 36.00 28.01 7.99 Staphylococcus aureus (0.0%) Staphylococcus aureus (few)
STA31 31.43 21.83 9.60 Staphylococcus aureus (0.0%) Staphylococcus aureus (medium)
STA41 33.48 23.12 10.36 Staphylococcus aureus (0.0%) Staphylococcus aureus (few)
STA43 28.08 21.00 7.08 Staphylococcus aureus (0.0%) Staphylococcus aureus (large)
STA44 31.43 20.11 11.32 Staphylococcus aureus (0.0%) Staphylococcus aureus (large)
clinical samples correctly identified the bacterial species that
were identified using culture-based methods. In most samples,
a few more species of the same genera or other genera were also
identified by NGS. In some samples, NGS allowed identification
of clinically relevant pathogens that often remain unidentified by
culture methods due to their challenging growth, such as GPAC
(Gram-positive anaerobic cocci) bacteria, Actinotignum sp., and
Streptococcus species (Murphy and Frick, 2013; Pedersen et al.,
2017). In other cases, theNGS results were not consistent with the
culture methods. In some cases, the NGS showed the dominating
unidentified species within the samples, and in others, a low-
quality PCR product was obtained. These problems may be
removed by obtaining more reference sequences for other genera
and using the NGS method for more clinical samples to slightly
improve the PCR conditions. Moreover, when differences can
be found within the whole 16S-23S rRNA region sequence, then
polymorphism within the species is the cause, and inclusion of a
higher number of reference sequences will improve the species-
level identification. Facilitating NGS 16S-23S rRNA data analyses
is crucial because at present, this method is quite complicated for
clinical samples since it is time consuming and the results may
be difficult to interpret. The new software that is being created
will be a great improvement for researchers. Importantly, positive
and negative controls should always be included to monitor the
whole process.
The rapid development of DNA sequencing techniques
has allowed substantial improvement of culture-independent
identification of microbial pathogens. Additionally, advances
in DNA sequencing techniques have allowed simultaneous
investigation of millions of DNA fragments and enabled rapid
identification of all microorganisms present in a given clinical
sample. NGS-based techniques, especially NGS of the 16S rRNA
gene, have been successfully applied for the comprehensive
analysis of microbiomes not only from healthy people but also
from microbiomes associated with many diseases (Jervis Bardy
and Psaltis, 2016; Jovel et al., 2016; Pérez-Losada et al., 2017).
Microbiome analysis could lead to reclassification of terms
such as “infectious agent” or “bacterial pathogen,” because any
microbiome appears to have one or more dominant bacteria
but also contains potentially important coconspirators that
may modulate growth, virulence, biofilm formation, quorum
sensing, and antibiotic resistance, and sensitive NGS-based
techniques enable their detection (Toma et al., 2014). In any
case, identification of microbiome constituents at the phylum
or genus level does not provide sufficient microbiological
details. This lack occurs because microbes at the species level
are transmitted between hosts and have different transmission
power, tenacity and biological behavior. NGS of the 16-23S
rRNA region allows polymicrobial diagnostics, and analysis of the
intergenic regions contained in this region significantly increases
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the identification potential of the method, allowing unambiguous
species identification.
In conclusion, our study demonstrated the reliability of NGS
of the 16S-23S rRNA region for staphylococcal identification
at the species level. The method based on NGS of the 16S-
23S region undoubtedly had the highest identification potential
of all of the methods used. We have developed a reference
dataset of the 16S-23S rRNA region for 50 staphylococcal
species (including one proposed species) and 6 subspecies.
Therefore, all clinically relevant staphylococcal species can be
detected in patient specimens at present. Expanding the database
in the future will allow this approach to constitute a highly
precise, rapid and reliable method for highly specific microbial
identification in general.
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